← Alle mensen

GR

Gareth Rivalland

3 publicaties

PubMed → Google Scholar →

Publicaties op Oncologisch.com

Vibostolimab coformulated with pembrolizumab versus pembrolizumab alone as adjuvant therapy for high-risk stage IIB-I...

The Lancet. Oncology · 2026-03

Vibostolimab-pembrolizumab versus pembrolizumab als adjuvante therapie bij hoogrisico stadium IIB-melanoom

The Lancet Oncology · 13 februari 2026

Tislelizumab versus docetaxel bij eerder behandeld NSCLC: RATIONALE-303 fase III

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer · 2023-01